Breaking News Instant updates and real-time market news.

FNLPF

Fresnillo

$0.00 /

+ (+0.00%)

 11:52
10/12/20
 10/12
11:52
 10/12/20
11:52

Fresnillo price target lowered to 1,300 GBp from 1,400 GBp at RBC Capital

RBC Capital analyst James Bell lowered the firm's price target on Fresnillo to 1,300 GBp from 1,400 GBp and keeps a Sector Perform rating on the shares.
FNLPF Fresnillo
$0.00 /

+ (+0.00%)

10/07/20 JPMorgan
Fresnillo price target raised to 1,200 GBp from 800 GBp at JPMorgan
10/06/20 Berenberg
Fresnillo upgraded to Hold from Sell at Berenberg
09/24/20 Morgan Stanley
Fresnillo price target raised to 1,350 GBp from 1,250 GBp at Morgan Stanley
09/15/20 Barclays
Fresnillo price target raised to 1,150 GBp from 800 GBp at Barclays

TODAY'S FREE FLY STORIES

Recommendations
Kirkland Lake Gold price target raised to C$52 from C$51 at National Bank » 10:47
04/23/21
04/23
10:47
04/23/21
10:47
KL

Kirkland Lake Gold

$38.32 /

-0.255 (-0.66%)

National Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KL Kirkland Lake Gold
$38.32 /

-0.255 (-0.66%)

04/09/21
Kirkland Lake Gold reports Q1 production of 302,847 ounces
03/01/21
Kirkland Lake Gold names Natasha Vaz as COO
01/12/21
Kirkland Lake Gold says Q4 production totalted 369,434 ounces, up 32% y/y
12/16/20
Kirkland Lake Gold raises quarterly dividend 50% to 18.75c per share
KL Kirkland Lake Gold
$38.32 /

-0.255 (-0.66%)

04/16/21 TD Securities
Kirkland Lake Gold upgraded to Action List Buy from Buy at TD Securities
04/06/21 Scotiabank
Kirkland Lake Gold price target lowered to C$61 from C$68 at Scotiabank
04/01/21 TD Securities
Kirkland Lake Gold price target raised to C$77 from C$75 at TD Securities
03/17/21 National Bank
Kirkland Lake downgraded to Sector Perform from Outperform at National Bank
KL Kirkland Lake Gold
$38.32 /

-0.255 (-0.66%)

11/05/20
Kirkland Lake Gold reports Q3 EPS 91c vs. 80c year-over-year
05/06/21
Kirkland Lake Gold - KL
KL Kirkland Lake Gold
$38.32 /

-0.255 (-0.66%)

11/24/20
Kirkland Lake Gold call volume above normal and directionally bullish
Hot Stocks
Liberty TripAdvisor Holdings trading resumes  10:46
04/23/21
04/23
10:46
04/23/21
10:46
 
Recommendations
Kinross Gold price target raised to C$14 from C$13.75 at National Bank » 10:46
04/23/21
04/23
10:46
04/23/21
10:46
KGC

Kinross Gold

$7.44 /

-0.1 (-1.33%)

National Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KGC Kinross Gold
$7.44 /

-0.1 (-1.33%)

02/10/21
Kinross Gold sees FY21 CapEx $900M, plus or minus 5%
02/10/21
Kinross Gold sees FY21 gold equivalent production 2.4M ounces
01/05/21
Gold Standard Ventures announces senior leadership changes
KGC Kinross Gold
$7.44 /

-0.1 (-1.33%)

02/11/21 Barclays
Kinross Gold price target raised to $10 from $9 at Barclays
02/10/21 JPMorgan
Kinross initiated with Overweight, added to Focus List at JPMorgan
02/08/21 Stifel
Kinross Gold price target lowered to C$14.50 from C$14.75 at Stifel
01/11/21 National Bank
Kinross Gold price target lowered to C$17.25 from C$18 at National Bank
KGC Kinross Gold
$7.44 /

-0.1 (-1.33%)

02/10/21
Kinross Gold reports Q4 adjusted EPS 27c, consensus 22c
11/04/20
Kinross Gold reports Q3 EPS ,25c consensus 21c
05/12/21
Kinross Gold - KGC
KGC Kinross Gold
$7.44 /

-0.1 (-1.33%)

04/15/21
Kinross Gold call volume above normal and directionally bullish
04/12/21
Kinross Gold call volume above normal and directionally bullish
04/09/21
Kinross Gold call volume above normal and directionally bullish
02/19/21
Kinross Gold put volume heavy and directionally bearish
Recommendations
Agnico Eagle price target lowered to C$97 from C$98 at National Bank » 10:45
04/23/21
04/23
10:45
04/23/21
10:45
AEM

Agnico Eagle

$65.86 /

-0.27 (-0.41%)

National Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AEM Agnico Eagle
$65.86 /

-0.27 (-0.41%)

02/16/21
Osisko Gold receives approval for Canadian Malartic Underground construction
02/11/21
Agnico Eagle sees 2021 gold production of 2.05M oz
01/20/21
TMAC receives final court approval for acquisition by Agnico Eagle
01/05/21
Agnico Eagle to acquire TMAC Resources for C$2.20 per share
AEM Agnico Eagle
$65.86 /

-0.27 (-0.41%)

02/23/21 Canaccord
Agnico Eagle price target lowered to C$110 from C$115 at Canaccord
02/23/21 Canaccord
Agnico Eagle selloff overdone, says Canaccord
02/10/21 JPMorgan
Agnico Eagle initiated with a Neutral at JPMorgan
02/02/21 National Bank
Agnico Eagle price target lowered to C$109 from C$112 at National Bank
AEM Agnico Eagle
$65.86 /

-0.27 (-0.41%)

02/11/21
Agnico Eagle reports Q4 adjusted EPS 67c, consensus 65c
10/28/20
Agnico Eagle reports Q3 adjusted EPS 78c, consensus 67c
04/30/21
Agnico Eagle - AEM
AEM Agnico Eagle
$65.86 /

-0.27 (-0.41%)

12/16/20
Largest borrow rate increases among liquid names
11/23/20
Largest borrow rate increases among liquid names
11/13/20
Largest borrow rate increases among liquid names
Syndicate
Agiliti indicated to open at $15-$16, IPO priced at $14 » 10:45
04/23/21
04/23
10:45
04/23/21
10:45
AGTI

Agiliti

$10.51 /

+ (+0.00%)

Agiliti (AGTI) priced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGTI Agiliti
$10.51 /

+ (+0.00%)

10:44 Today
Agiliti indicated to open at $15-$16, IPO priced at $14
  • 23
    Apr
Options
Futu Holdings call volume above normal and directionally bullish » 10:45
04/23/21
04/23
10:45
04/23/21
10:45
FUTU

Futu Holdings

$139.99 /

+3.99 (+2.93%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FUTU Futu Holdings
$139.99 /

+3.99 (+2.93%)

04/19/21
Futu Holdings drops 6% to $167.25 after 9.5M ADS offering
12/08/20
Futu Holdings announces agreement to purchase shares by investment firm
FUTU Futu Holdings
$139.99 /

+3.99 (+2.93%)

03/17/21 Citi
Futu Holdings price target lowered to $230.30 from $246.50 at Citi
02/26/21 Citi
Futu Holdings price target raised to $246.50 from $119.70 at Citi
02/22/21 86 Research
Futu Holdings downgraded to Hold from Buy at 86 Research
02/16/21 Morgan Stanley
Futu Holdings initiated with an Overweight at Morgan Stanley
  • 21
    Apr
  • 19
    Aug
FUTU Futu Holdings
$139.99 /

+3.99 (+2.93%)

02/19/21
China considers loosening restrictions on offshore investments, Bloomberg says
FUTU Futu Holdings
$139.99 /

+3.99 (+2.93%)

04/20/21
Fly Intel: Wall Street's top stories for Tuesday
04/20/21
Fly Intel: Wall Street's top stories at midday
04/19/21
Fly Intel: After-Hours Movers
02/19/21
Fly Intel: Pre-market Movers
FUTU Futu Holdings
$139.99 /

+3.99 (+2.93%)

08:45 Today
Largest borrow rate increases among liquid names
04/21/21
Futu Holdings put volume heavy and directionally bearish
04/13/21
Largest borrow rate increases among liquid names
04/01/21
Largest borrow rate increases among liquid names
Hot Stocks
Liberty TripAdvisor Holdings trading halted, volatility trading pause  10:41
04/23/21
04/23
10:41
04/23/21
10:41
 
Syndicate
Treace Medical indicated to open at $22, IPO priced at $17 » 10:36
04/23/21
04/23
10:36
04/23/21
10:36
TMCI

Treace Medical

/

+

Treace Medical Concepts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 23
    Apr
Hot Stocks
AnaptysBio granted conditional marketing authorization for JEMPERLI » 10:36
04/23/21
04/23
10:36
04/23/21
10:36
ANAB

AnaptysBio

$23.51 /

+0.63 (+2.75%)

, GSK

GlaxoSmithKline

$37.58 /

-0.1 (-0.27%)

AnaptysBio (ANAB)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

04/22/21
FDA approves Jemperli for dMMR endometrial cancer
04/22/21
GlaxoSmithKline confirms FDA approval for Jemperli
04/22/21
FDA grants approval to Jemperli for endometrial cancer with specific biomarker
03/10/21
AnaptysBio rises 8.7% after Ecor1 increased stake to 7.15M shares
GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

10:22 Today
GlaxoSmithKline reports European Commission approves Jemperli
06:41 Today
Roche announces FDA approval of VENTANA MMR RxDx panel
04/22/21
GlaxoSmithKline announces FDA approval of JEMPERLI
04/22/21
FDA approves Jemperli for dMMR endometrial cancer
ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

03/16/21
Fly Intel: Top five analyst upgrades
03/16/21 Truist
AnaptysBio upgraded to Buy from Hold at Truist
03/16/21 Truist
AnaptysBio upgraded to Buy from Hold at Truist
03/09/21 Wedbush
AnaptysBio downgraded to Neutral at Wedbush
GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

04/20/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
04/20/21 UBS
GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
04/20/21 Citi
GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi
03/23/21
Fly Intel: Top five analyst downgrades
ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

02/25/21
AnaptysBio reports Q4 EPS $1.20, consensus $1.39
11/04/20
AnaptysBio reports Q3 EPS (87c), consensus (72c)
GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

02/03/21
GlaxoSmithKline reports Q4 adjusted EPS 23.3p vs. 24.8p a year ago
10/28/20
GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range
10/28/20
GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago
GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

04/15/21
Activist Elliott builds 'multibillion-pound' stake in GlaxoSmithKline, FT says
02/09/21
Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports
01/12/21
GSK looks to double blockbusters in portfolio by 2026, Bloomberg says
12/31/20
Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports
ANAB AnaptysBio
$23.51 /

+0.63 (+2.75%)

03/08/21
Fly Intel: Wall Street's top stories for Monday
03/08/21
Fly Intel: Wall Street's top stories at midday
02/11/21
Zillow, Bed Bath & Beyond upgrades among today's top calls on Wall Street
GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

03/11/21
Fly Intel: Wall Street's top stories for Thursday
03/11/21
Fly Intel: Wall Street's top stories at midday
02/22/21
Fly Intel: Wall Street's top stories for Monday
02/22/21
Fly Intel: Wall Street's top stories at midday
05/24/21
Global Healthcare Virtual Conference 2021
04/28/21
GlaxoSmithKline - GSK
GSK GlaxoSmithKline
$37.58 /

-0.1 (-0.27%)

04/15/21
Unusually active option classes on open April 15th
Options
Rite Aid put volume heavy and directionally bearish » 10:35
04/23/21
04/23
10:35
04/23/21
10:35
RAD

Rite Aid

$18.33 /

+0.14 (+0.77%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

03/25/21
Rite Aid falls -22.7%
03/25/21
Rite Aid falls -17.6%
03/24/21
Rite Aid narrows FY21 net loss view to ($100M) to ($90M) from ($114M) to ($89M)
03/24/21
Rite Aid falls over 14% below $20 after FY21 guidance cut
RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

03/25/21 Deutsche Bank
Rite Aid price target raised to $27 from $17 at Deutsche Bank
03/25/21 Deutsche Bank
Rite Aid named short-term buy idea at Deutsche Bank
12/18/20 Deutsche Bank
Rite Aid price target raised to $17 from $9 at Deutsche Bank
11/17/20 Oppenheimer
Amazon's Pharmacy push should continue to disrupt supply chain, says Oppenheimer
RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

04/15/21
Rite Aid sees Q1 revenue $6.1B-$6.3B, consensus $6.05B
04/15/21
Rite Aid reports Q4 EPS (78c), consensus (76c)
03/24/21
Rite Aid sees FY21 revenue approx. $24.0B, consensus $24.07B
12/17/20
Rite Aid raises FY21 adjusted EPS view to 45c-85c from (67c)-9c, consensus (9c)
RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

04/15/21
Fly Intel: Pre-market Movers
03/25/21
Fly Intel: Wall Street's Top Stories for Thursday
03/25/21
Fly Intel: Pre-market Movers
03/24/21
Fly Intel: After-Hours Movers
RAD Rite Aid
$18.33 /

+0.14 (+0.77%)

04/20/21
Rite Aid put volume heavy and directionally bearish
03/31/21
Rite Aid call volume above normal and directionally bullish
03/26/21
Rite Aid call volume above normal and directionally bullish
03/16/21
Rite Aid call volume above normal and directionally bullish
General news
Oil Action: WTI crude » 10:35
04/23/21
04/23
10:35
04/23/21
10:35
$ECON

Economic Data

/

+

Oil Action: WTI crude…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
    Recommendations
    Inter Pipeline price target raised to C$18 from C$17.50 at Scotiabank » 10:34
    04/23/21
    04/23
    10:34
    04/23/21
    10:34
    IPPLF

    Inter Pipeline

    $14.50 /

    +0.2918 (+2.05%)

    Scotiabank analyst Robert…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    IPPLF Inter Pipeline
    $14.50 /

    +0.2918 (+2.05%)

    03/11/21
    Brookfield Infrastructure comments on Inter Pipeline directors' circular
    IPPLF Inter Pipeline
    $14.50 /

    +0.2918 (+2.05%)

    07:39 Today Stifel
    Inter Pipeline downgraded to Hold at Stifel on strategic review uncertainty
    04/22/21 Stifel
    Inter Pipeline downgraded to Hold from Buy at Stifel
    04/06/21 Stifel
    Inter Pipeline price target raised to C$20.50 from C$20 at Stifel
    02/24/21 National Bank
    Inter Pipeline price target raised to C$18 from C$15 at National Bank
    Recommendations
    CGI Inc. price target raised to C$112 from C$106 at Scotiabank » 10:34
    04/23/21
    04/23
    10:34
    04/23/21
    10:34
    GIB

    CGI Inc.

    $85.50 /

    -0.02 (-0.02%)

    Scotiabank analyst Paul…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GIB CGI Inc.
    $85.50 /

    -0.02 (-0.02%)

    03/30/21
    CGI Inc. selected for Federal Reserve Bank's FedNow service pilot
    03/23/21
    CGI creates 600 jobs at Lafayette delivery center, expects to reach 800 by 2023
    03/11/21
    CGI Inc. awarded contract by Bavarian State Ministry of Justice
    02/26/21
    CGI Inc. announces IT delivery center in Knoxville, Tennessee
    GIB CGI Inc.
    $85.50 /

    -0.02 (-0.02%)

    04/12/21 Societe Generale
    CGI Inc. upgraded to Hold from Sell at Societe Generale
    03/23/21 Desjardins
    CGI Inc. resumed with a Buy at Desjardins
    03/04/21 Edward Jones
    CGI Inc. upgraded to Buy from Hold at Edward Jones
    02/01/21 Barclays
    CGI Inc. price target raised to $89 from $80 at Barclays
    GIB CGI Inc.
    $85.50 /

    -0.02 (-0.02%)

    01/27/21
    CGI Inc. reports Q1 ex-items EPS C$1.33 vs. C$1.23 last year
    11/11/20
    CGI Inc. reports Q4 EPS C$1.22, vs. C$1.21 last year
    04/28/21
    CGI Inc. - GIB
    Syndicate
    Rain Therapeutics indicated to open at $27, IPO priced at $17 » 10:33
    04/23/21
    04/23
    10:33
    04/23/21
    10:33
    RAIN

    Rain Therapeutics

    /

    +

    Rain Therapeutics (RAIN)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    • 23
      Apr
    Syndicate
    Latham Group indicated to open at $22, IPO priced at $19 » 10:32
    04/23/21
    04/23
    10:32
    04/23/21
    10:32
    SWIM

    Latham Group

    /

    +

    Latham Group (SWIM)…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    • 23
      Apr
    SWIM Latham Group
    /

    +

    04/17/21
    Opening Day: Coinbase soars in market debut
    04/10/21
    Opening Day: Phone maker UTime soars in public debut
    04/03/21
    Opening Day: Softbank-backed Compass raises $450M in IPO
    Options
    Bristol Myers Squibb call volume above normal and directionally bullish » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25
    BMY

    Bristol-Myers

    $66.89 /

    +0.57 (+0.86%)

    Bullish option flow…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    10:03 Today
    Bristol-Myers says Phase 3 trials of deucravacitinib met co-primary endpoints
    06:54 Today
    Bristol-Myers announces EMA's CHMP recommends approval of Onureg in Europe
    06:47 Today
    Bristol-Myers announces EMA's CHMP recommends approval of Opdivo
    04/16/21
    Bristol-Myers confirms FDA approves Opdivo combo for gastric cancer
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/21/21 Citi
    Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
    04/21/21 Citi
    Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
    04/13/21 Truist
    Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
    04/13/21 Truist
    Bristol-Myers upgraded to Buy from Hold at Truist
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    03/04/21
    Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c)
    02/24/21
    CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M
    02/04/21
    Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45
    02/04/21
    Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/01/21
    Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports
    02/15/21
    Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports
    12/23/20
    Judge rules against White House drug pricing rule, Reuters says
    11/23/20
    EU seeks easier access to generic medicines, Reuters says
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/13/21
    FedEx, Booking Holdings upgrades among today's top calls on Wall Street
    03/29/21
    Fly Intel: Pre-market Movers
    02/09/21
    Fly Intel: Pre-market Movers
    12/26/20
    Week in review: How Trump's policies moved stocks
    11:00 Today
    Pharmaceuticals
    12:00 Today
    Biotechnology
    04/29/21
    Bristol-Myers - BMY
    04/29/21
    Oncologic Drugs Advisory Committee Virtual Meeting
    05/20/21
    PDUFA Date for CM-577 - Opdivo
    05/25/21
    PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo
    05/30/21
    PDUFA Date for Zeposia (Ozanimod)
    01/28/22
    PDUFA Date for Mavacamten
    05/04/21
    Bristol Myers Squibb Co
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/07/21
    Unusually active option classes on open April 7th
    01/20/21
    Unusually active option classes on open January 20th
    01/11/21
    Unusually active option classes on open January 11th
    01/05/21
    Bristol Myers Squibb call volume above normal and directionally bullish
    Conference/Events
    Cowen pharmaceuticals analysts to hold analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25
    BMY

    Bristol-Myers

    $66.89 /

    +0.57 (+0.86%)

    Pharmaceuticals Analysts…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    10:03 Today
    Bristol-Myers says Phase 3 trials of deucravacitinib met co-primary endpoints
    06:54 Today
    Bristol-Myers announces EMA's CHMP recommends approval of Onureg in Europe
    06:47 Today
    Bristol-Myers announces EMA's CHMP recommends approval of Opdivo
    04/16/21
    Bristol-Myers confirms FDA approves Opdivo combo for gastric cancer
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/21/21 Citi
    Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
    04/21/21 Citi
    Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
    04/13/21 Truist
    Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
    04/13/21 Truist
    Bristol-Myers upgraded to Buy from Hold at Truist
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    03/04/21
    Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c)
    02/24/21
    CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M
    02/04/21
    Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45
    02/04/21
    Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/01/21
    Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports
    02/15/21
    Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports
    12/23/20
    Judge rules against White House drug pricing rule, Reuters says
    11/23/20
    EU seeks easier access to generic medicines, Reuters says
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/13/21
    FedEx, Booking Holdings upgrades among today's top calls on Wall Street
    03/29/21
    Fly Intel: Pre-market Movers
    02/09/21
    Fly Intel: Pre-market Movers
    12/26/20
    Week in review: How Trump's policies moved stocks
    11:00 Today
    Pharmaceuticals
    12:00 Today
    Biotechnology
    04/29/21
    Bristol-Myers - BMY
    04/29/21
    Oncologic Drugs Advisory Committee Virtual Meeting
    05/20/21
    PDUFA Date for CM-577 - Opdivo
    05/25/21
    PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo
    05/30/21
    PDUFA Date for Zeposia (Ozanimod)
    01/28/22
    PDUFA Date for Mavacamten
    05/04/21
    Bristol Myers Squibb Co
    BMY Bristol-Myers
    $66.89 /

    +0.57 (+0.86%)

    04/07/21
    Unusually active option classes on open April 7th
    01/20/21
    Unusually active option classes on open January 20th
    01/11/21
    Unusually active option classes on open January 11th
    01/05/21
    Bristol Myers Squibb call volume above normal and directionally bullish
    Conference/Events
    Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25

    Large Cap & Biopharma…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Conference/Events
    UBS technology analyst to hold an analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25

    Technology Analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Conference/Events
    Truist digital advertising analysts to hold analyst/industry conference call » 10:25
    04/23/21
    04/23
    10:25
    04/23/21
    10:25

    Digital Ad Analysts,…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial
    Hot Stocks
    Allegiance Bancshares approves stock repurchase authorization up to 1M shares » 10:24
    04/23/21
    04/23
    10:24
    04/23/21
    10:24
    ABTX

    Allegiance Bancshares

    $39.02 /

    + (+0.00%)

    On April 22, 2021, the…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    10:23 Today
    Allegiance Bancshares appoints Raimundo Riojas to board of directors
    01/28/21
    Allegiance Bancshares raises quarterly dividend 20% to 12c per share
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    10/02/20 Janney Montgomery Scott
    Allegiance Bancshares initiated with a Neutral at Janney Montgomery Scott
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    01/28/21
    Allegiance Bancshares reports Q4 EPS 77c, consensus 71c
    10/29/20
    Allegiance Bancshares reports Q3 EPS 79c, consensus 52c
    04/29/21
    Allegiance Bancshares - ABTX
    Recommendations
    WeCommerce price target lowered to C$23 from C$26 at TD Securities » 10:23
    04/23/21
    04/23
    10:23
    04/23/21
    10:23
    WECMF

    WeCommerce

    $14.79 /

    +0.4312 (+3.00%)

    TD Securities analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    Hot Stocks
    Allegiance Bancshares appoints Raimundo Riojas to board of directors » 10:23
    04/23/21
    04/23
    10:23
    04/23/21
    10:23
    ABTX

    Allegiance Bancshares

    $39.02 /

    + (+0.00%)

    Allegiance Bancshares…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    01/28/21
    Allegiance Bancshares raises quarterly dividend 20% to 12c per share
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    10/02/20 Janney Montgomery Scott
    Allegiance Bancshares initiated with a Neutral at Janney Montgomery Scott
    ABTX Allegiance Bancshares
    $39.02 /

    + (+0.00%)

    01/28/21
    Allegiance Bancshares reports Q4 EPS 77c, consensus 71c
    10/29/20
    Allegiance Bancshares reports Q3 EPS 79c, consensus 52c
    04/29/21
    Allegiance Bancshares - ABTX
    Recommendations
    Intact Financial price target raised to C$185 from C$175 at TD Securities » 10:22
    04/23/21
    04/23
    10:22
    04/23/21
    10:22
    IFCZF

    Intact Financial

    $130.32 /

    -0.03 (-0.02%)

    TD Securities analyst…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return tomorrow

    Get Free Trial

    ShowHide Related Items >><<
    IFCZF Intact Financial
    $130.32 /

    -0.03 (-0.02%)

    02/12/21 Desjardins
    Intact Financial price target raised to C$175 from C$170 at Desjardins
    02/10/21 National Bank
    Intact Financial price target raised to C$200 from C$192 at National Bank
    02/10/21 TD Securities
    Intact Financial price target raised to C$175 from C$170 at TD Securities
    12/08/20 Scotiabank
    Intact Financial price target raised to C$175 from C$166 at Scotiabank
    Hot Stocks
    GlaxoSmithKline reports European Commission approves Jemperli » 10:22
    04/23/21
    04/23
    10:22
    04/23/21
    10:22
    GSK

    GlaxoSmithKline

    $37.65 /

    -0.03 (-0.08%)

    GlaxoSmithKline announced…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    06:41 Today
    Roche announces FDA approval of VENTANA MMR RxDx panel
    04/22/21
    GlaxoSmithKline announces FDA approval of JEMPERLI
    04/22/21
    FDA approves Jemperli for dMMR endometrial cancer
    04/22/21
    GlaxoSmithKline confirms FDA approval for Jemperli
    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    04/20/21 Morgan Stanley
    GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
    04/20/21 UBS
    GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
    04/20/21 Citi
    GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi
    03/23/21
    Fly Intel: Top five analyst downgrades
    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    02/03/21
    GlaxoSmithKline reports Q4 adjusted EPS 23.3p vs. 24.8p a year ago
    10/28/20
    GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range
    10/28/20
    GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago
    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    04/15/21
    Activist Elliott builds 'multibillion-pound' stake in GlaxoSmithKline, FT says
    02/09/21
    Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports
    01/12/21
    GSK looks to double blockbusters in portfolio by 2026, Bloomberg says
    12/31/20
    Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports
    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    03/11/21
    Fly Intel: Wall Street's top stories for Thursday
    03/11/21
    Fly Intel: Wall Street's top stories at midday
    02/22/21
    Fly Intel: Wall Street's top stories for Monday
    02/22/21
    Fly Intel: Wall Street's top stories at midday
    05/24/21
    Global Healthcare Virtual Conference 2021
    04/28/21
    GlaxoSmithKline - GSK
    GSK GlaxoSmithKline
    $37.65 /

    -0.03 (-0.08%)

    04/15/21
    Unusually active option classes on open April 15th

    Get Full Fly Access

    Breaking market intelligence sent straight to you
    Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
    Up-to-date information on important industry events
    Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
    News focused on the companies in your portfolio
    Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.